Calcium ion channels in the membrane of vascular smooth muscle (VSM) cells play an important role in excitation-contraction coupling and in setting vasomotor tone. Ca2+ channels may be regulated either directly or indirectly by neurotransmitters, vasoactive hormones and therapeutic agents; regulatory processes may include the formation or release of intracellular messengers such as Ca2+, cAMP, cGMP, IP3/IP4, and diacylglycerol. The objective of the proposed studies is to investigate in detail the specific characteristics and regulatory mechanisms of calcium channels in freshly-isolated VSM cells from several different types of vessels in the rat (small mesenteric artery, aorta, portal vein). Since blood vessels from different vascular beds have different degrees of excitability, the proportion of various ion channels and/or their regulatory processes may differ. Macroscopic and microscopic (single-channel) Ca2+ current (ICa) will be recorded using whole-cell voltage clamp and patch clamp techniques. Intracellular agents will be delivered through the use of the intracellular perfusion technique. A possible role of phosphorylation, mediated by various protein kinases (PK), in regulating ICa will be explored.
Specific aims i nclude: (1) Assessing the role of cAMP- and cGMP-dependent PK systems (PK-A and PK- G) and the effect of phosphorylation and dephosphorylation on ICa. Techniques will include the application of cyclic nucleotide analogs, PK-A (cat subunit) and PK-G, and phosphatases (PPases), as well as the use of PK and PPase inhibitors. (2) The role of PK-C in the modulation of ICa, will be explored. Responses to exogenous PK-C activators (i.e. DAG, OAG), to purified PK-C, and to PK inhibitors will be determined. (3) The role of Ca2+-calmodulin-dependent PK (Ca/CaM- PKII), will be investigated using specific activators and inhibitors of this PK. The influence of intracellular levels of calcium on Ca2+ channel activity will also be studied. (4) The role of metabolism and intracellular levels of ATP on ICa will be further studied through the use of stable ATP analogs, phosphorylation blockers and metabolic poisons. (Preliminary data showed that lowering intracellular ATP levels inhibited Ca2+ channel activity and ICa.) (5) The modulation of ICa by G-proteins and G-protein gating will be examined. The results of these studies should provide comprehensive information on the complex mechanisms involved in calcium channel regulation in VSM cells, and should help to define how calcium influx, cellular excitability, and contraction are altered by important vasoactive substances.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL040572-04A3
Application #
2219656
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1990-07-01
Project End
1998-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Physiology
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Sunagawa, M; Nakamura, M; Kosugi, T et al. (2001) Lack of tyrosine protein kinase regulation of L-type Ca2+ channel current in transfected cells stably expressing alpha1C-b Subunit. Jpn J Physiol 51:115-9
Nakamura, M; Sunagawa, M; Kosugi, T et al. (2000) Actin filament disruption inhibits L-type Ca(2+) channel current in cultured vascular smooth muscle cells. Am J Physiol Cell Physiol 279:C480-7
Yokoshiki, H; Seki, T; Sunagawa, M et al. (2000) Inhibition of Ca2+-activated K+ channels by tyrosine phosphatase inhibitors in rat mesenteric artery. Can J Physiol Pharmacol 78:745-50
Yokoshiki, H; Sunagawa, M; Seki, T et al. (1999) Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells. Pflugers Arch 437:400-8
Sunagawa, M; Yokoshiki, H; Seki, T et al. (1999) Direct block of Ca2+ channels by calmidazolium in cultured vascular smooth muscle cells. J Cardiovasc Pharmacol 34:488-96
Seki, T; Yokoshiki, H; Sunagawa, M et al. (1999) Angiotensin II stimulation of Ca2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002. Pflugers Arch 437:317-23
Katsube, Y; Yokoshiki, H; Sunagawa, M et al. (1998) Carbachol inhibition of Ca2+ currents in ventricular cells obtained from neonatal and adult rats. Eur J Pharmacol 358:269-75
Katsube, Y; Yokoshiki, H; Nguyen, L et al. (1998) L-type Ca2+ currents in ventricular myocytes from neonatal and adult rats. Can J Physiol Pharmacol 76:873-81
Sunagawa, M; Yokoshiki, H; Seki, T et al. (1998) Intracellular application of calmidazolium increases Ca2+ current through activation of protein kinase A in cultured vascular smooth muscle cells. J Vasc Res 35:303-9
Yokoshiki, H; Katsube, Y; Sunugawa, M et al. (1997) Disruption of actin cytoskeleton attenuates sulfonylurea inhibition of cardiac ATP-sensitive K+ channels. Pflugers Arch 434:203-5

Showing the most recent 10 out of 23 publications